Intellihealth

Milliman published an independent evaluation of FlyteHealth’s first-year partnership with the State of Connecticut. The results make a strong case for what whole-person obesity care can deliver when it’s done right.

FlyteHealth joins the **CMS Health Tech Ecosystem** in the **Diabetes and Obesity** category. The company’s **eCKM care platform** addresses chronic conditions like hypertension, hyperlipidemia, prediabetes, kidney disease, and obesity. This selection highlights FlyteHealth’s focus on integrated care solutions for Medicare and Medicaid beneficiaries.

Jun 2026Yahoo FinanceNews article

FlyteHealth’s program with the State of Connecticut achieves **$30 million in pharmacy cost avoidance** and **significant medical cost savings** through its care coordination model. The evaluation highlights reduced spending by optimizing medication adherence and care transitions for Medicaid beneficiaries. Results show measurable financial benefits while improving patient outcomes.

May 2026PR NewswireNews article

FlyteHealth is offering self-insured employers direct access to obesity management medications. The company specializes in integrated care for cardio-kidney-metabolic conditions and aims to broaden medication availability for workplace health programs. This expansion targets employers seeking to enhance employee wellness through pharmaceutical interventions.

Dec 2025PR NewswireNews article

FlyteHealth appoints Dr. Cheryl Pegus as Chief Executive Officer and Board Chair. The company specializes in cardiometabolic care and is expanding its executive leadership to support growth in specialized healthcare solutions.

Aug 2025citybizNews article